Petco Q1 Comps Turn Positive, Reaffirms FY26 Sales and Profit Outlook
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Petco Health and Wellness Company reported a return to positive comparable sales for the first quarter of its fiscal 2026 period. The company reaffirmed its full-year 2026 outlook for net sales to be flat to up 1.5% and for adjusted EBITDA to land between $415 million and $430 million. This guidance was detailed in reporting from seekingalpha.com on June 4, 2026, providing a crucial update on the retailer's multi-year turnaround efforts. The positive comparable sales figure marks a notable break from a string of prior quarterly declines, signaling potential stabilization in a challenging retail environment for pet specialty stores.
The positive comparable sales figure arrives after a prolonged period of contraction for Petco and its peers. The company last reported positive quarterly comparable sales growth in Q4 2024, which was a modest 0.3% increase. Following that, comparable sales fell 1.9% in Q1 2025, 2.4% in Q2 2025, and 1.1% in Q3 2025, illustrating a persistent demand headwind. The current macro backdrop features persistent inflation in services, though goods inflation has moderated, with the 10-year Treasury yield trading near 4.2%. What changed to trigger the Q1 2026 improvement is a likely combination of strategic initiatives finally gaining traction. Petco has been aggressively expanding its veterinary hospital footprint and refining its private label offerings, which carry higher margins. A potential easing of consumer pressure on discretionary budgets for pet care, following sustained wage growth, may also be contributing to the inflection point.
The reaffirmed guidance provides four concrete data points for fiscal year 2026. Net sales are projected to range between flat performance and growth of 1.5% year-over-year. Adjusted EBITDA is forecast between $415 million and $430 million. This compares to the company's reported adjusted EBITDA of $397.5 million for the full fiscal year 2025. The implied guidance represents a potential year-over-year improvement of 4.4% at the midpoint of the range. The positive Q1 comparable sales result stands in contrast to broader retail trends; the SPDR S&P Retail ETF (XRT) is down approximately 5% year-to-date in 2026, while the S&P 500 is up roughly 8%. Petco's market capitalization stands near $1.8 billion, a fraction of competitor Chewy's $12 billion valuation. The company's gross margin has been under pressure, declining from 40.1% in FY 2023 to an estimated 38.5% in FY 2025, a trend management aims to reverse.
| Metric | FY 2025 Actual | FY 2026 Guidance | Implied Change at Midpoint |
|---|---|---|---|
| Adjusted EBITDA | $397.5M | $415M - $430M | +6.0% |
| Net Sales Growth | -1.8% | 0% to +1.5% | +0.75 ppt improvement |
The positive comp and reaffirmed outlook provide a tangible data point for a potential bottom in the beleaguered brick-and-mortar retail sector. Specific tickers that could see correlated sentiment include other specialty retailers facing similar consumer pressures, such as Dick's Sporting Goods (DKS) and Williams-Sonoma (WSM). A sustained recovery at Petco would benefit suppliers like Central Garden & Pet (CENT), which derives significant revenue from the pet specialty channel. Conversely, pure-play e-commerce competitor Chewy (CHWY) may face renewed competitive pressure if Petco's omnichannel strategy regains momentum, potentially compressing CHWY's valuation premium. A key limitation to the bullish thesis is that reaffirming guidance is not the same as raising it; the unchanged outlook suggests management remains cautious despite the Q1 improvement. Positioning data shows short interest in Petco stock remained elevated at over 15% of float prior to this news, indicating significant skepticism. A sustained rally could force covering by these short sellers, amplifying upward price moves.
The next major catalyst for Petco is the formal release of its Q1 2026 earnings report, expected in late July 2026. Investors will scrutinize the exact magnitude of the positive comparable sales figure and any commentary on margin trends within the quarter. Following that, the Q2 2026 earnings report in October will be critical for confirming whether the positive comp trend is durable or a one-quarter anomaly. Key levels to watch for the stock include the $3.50 per share level, which has acted as recent resistance, and the 200-day moving average, currently near $4.15. If Petco's earnings confirm margin expansion alongside sales stabilization, the stock could break through these technical ceilings. Should consumer spending data weaken in the second half of 2026, however, the company's full-year EBITDA guidance at the lower end of its range would become the more likely outcome.
For retail investors, Petco's positive comparable sales indicate the company's fundamental business may be stabilizing after a difficult period. This is a key operational metric that shows consumer demand in its stores and online is no longer contracting. However, the reaffirmed, not raised, full-year guidance suggests management is taking a cautious view. Investors should monitor upcoming earnings calls for details on customer traffic, average transaction value, and the performance of high-margin services like veterinary care to gauge the sustainability of the turnaround. The stock's reaction will hinge on whether this is a true inflection or a temporary respite.
Petco's projected FY 2026 adjusted EBITDA of up to $430 million remains below its pre-pandemic profitability. In fiscal year 2019, Petco generated $450 million in adjusted EBITDA. The current guidance midpoint of $422.5 million represents a 6.1% decline from that level, highlighting the persistent operational and competitive challenges the company has faced. Net sales have grown from $4.4 billion in FY 2019 to an estimated $6.2 billion in FY 2025, but this expansion has come with significant margin compression, underscoring the difficulty of translating top-line growth into bottom-line profit in the current retail climate.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.